Perceptive Advisors’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-121,001
| Closed | -$2.22M | – | 152 |
|
|
2021
Q4 | $2.22M | Sell |
121,001
-8,470
| -7% | -$156K | 0.03% | 132 |
|
|
2021
Q3 | $3.24M | Sell |
129,471
-191,304
| -60% | -$4.79M | 0.05% | 124 |
|
|
2021
Q2 | $20.3M | Sell |
320,775
-55,556
| -15% | -$3.51M | 0.26% | 82 |
|
|
2021
Q1 | $46.4M | Buy |
376,331
+58,603
| +18% | +$7.22M | 0.59% | 44 |
|
|
2020
Q4 | $36.1M | Hold |
317,728
| – | – | 0.39% | 57 |
|
|
2020
Q3 | $38M | Hold |
317,728
| – | – | 0.55% | 47 |
|
|
2020
Q2 | $39.6M | Buy |
317,728
+225,545
| +245% | +$28.1M | 0.64% | 38 |
|
|
2020
Q1 | $17.5M | Buy |
+92,183
| New | +$17.5M | 0.45% | 43 |
|
|
2018
Q3 | – | Sell |
-17,240
| Closed | -$10.1M | – | 132 |
|
|
2018
Q2 | $10.1M | Sell |
17,240
-4,968
| -22% | -$2.9M | 0.26% | 59 |
|
|
2018
Q1 | $60.1M | Buy |
+22,208
| New | +$60.1M | 1.68% | 17 |
|